Unknown
ROYALTY PHARMA PLC
Smart-money confidence
· 1 of 3 sources firing
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
38
Congress
0
Insiders
50
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
◆ Next steps
Interested in ROYALTY PHARMA PLC? Here's what to do with it.
◇
Compare with other stocks
Sort 7,111 stocks by confidence, holders, or Congress signal
◈
Backtest the strategy
See how the model has done historically before you commit real money
✉
Get the weekly digest
One email on Sunday · what changed in the model this week
Not financial advice. Bogen Capital surfaces public SEC filings — you decide what to do with them.
Who's behind the signal
Every informed buyer we can see on ROYALTY PHARMA PLC, across all three feeds.
Hedge funds · 7
Point72 (Steve Cohen)
New position
Tudor Investment (Paul Tudor Jones)
Increased +7%
Citadel Advisors
Increased +1236%
AQR Capital Management
Increased +31%
D.E. Shaw & Co
Increased +499%
Baillie Gifford & Co
Decreased −2%
+1 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar.
ROYALTY PHARMA PLC isn't in the top-10 model right now, but 7 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
7
Investors
1
New positions
4
Increasing
2
Decreasing
0
Unchanged
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.1×
% of portfolio
0.0%
Position change
NEW
0.0% of Point72's portfolio
Trust weight: 1.2×
% of portfolio
0.2%
Position change
+7%
0.2% of Tudor Investment's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+1236%
0.1% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+31%
0.1% of AQR Capital Management's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+499%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.4×
% of portfolio
0.6%
Position change
−2%
0.6% of Baillie Gifford & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−95%
0.0% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to ROYALTY PHARMA PLC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell ROYALTY PHARMA PLC or any security.
Get the Weekly Update
Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime